Novo Nordisk has appointed George Godfrey as Senior Director for Medical and Regulatory in the UK.
Godfrey brings over twenty years’ experience at the forefront of healthcare delivery to Novo Nordisk, in a career journey that spans clinical medicine, pharmaceutical leadership and healthcare system transformation. In this role he will lead the UK’s medical and regulatory functions.
Godfrey previously served as Head of Medical for Respiratory and Immunology for AstraZeneca UK, where he led multidisciplinary medical teams. Prior to this, George spent two years in Switzerland as Regional Medical Director for Cardiovascular, Renal and Metabolism across Europe and Canada. Before moving into the pharmaceutical industry, George worked as a trained physician in anaesthesia and intensive care medicine, experience that continues to shape his commitment to translating scientific innovation into meaningful improvements in patient care.
Godfrey commented: “Working as a physician you see the unmet needs many patients face first-hand, day in, day out. Our industry has the opportunity to bring scientific advances to patients to try to change these realities, and in our field of medical and regulatory, we are privileged to work so closely to the groundbreaking science that sits behind that.”